Search for: "By Andrew Pollack"
Results 1 - 20
of 86
Sorted by Relevance
|
Sort by Date
25 Jul 2011, 6:36 am
Interesting article in yesterday's NY Times, by Andrew Pollack. [read post]
30 Jul 2011, 5:35 pm
Updating this brief ILB entry from Friday, here is a longer report from today's NYTimes, by Andrew Pollack. [read post]
10 Mar 2009, 1:21 pm
" Pollack discussed the [read post]
28 Nov 2011, 3:45 pm
., by Andrew Pollack: Medical researchers are again in pursuit of a goal they had all but abandoned: curing AIDS. [read post]
2 May 2007, 5:14 pm
Coli, by Andrew Pollack. [read post]
17 May 2012, 9:45 pm
The New York Times: A Stem-Cell-Based Drug Gets Approval in Canada, by Andrew Pollack: In a boost for the field of regenerative medicine, a small biotechnology company has received regulatory approval in Canada for what it says is the first... [read post]
1 May 2007, 12:04 pm
In today's New York Times, Andrew Pollack reported on the development two E. coli vaccines - one for humans and one for cattle. [read post]
18 Oct 2011, 8:58 pm
The New York Times: A Less Risky Down Syndrome Test Is Developed, by Andrew Pollack: New tests are coming to market that can detect Down syndrome in a fetus using a sample of the mother’s blood, potentially reducing the need... [read post]
12 May 2007, 4:27 pm
Panel Seeks Limits on Cancer Patient Drugs, by Andrew Pollack. [read post]
7 May 2008, 6:34 pm
NY Times: California Awards $271 Million for Stem Cell Research, by Andrew Pollack: California has awarded $271 million in grants to build 12 new stem cell research centers in the state, even as one of the political rationales for the... [read post]
9 May 2007, 12:49 pm
Article in the New York Times -- Doctors Reap Millions for Anemia Drugs, by Alex Berenson and Andrew Pollack. [read post]
15 Jul 2016, 8:15 am
Note the article in the New York Times by Andrew Pollack about Crestor titledAstraZeneca Pushes to Protect Crestor From Generic CompetitionNote separately the article by Murphy: Unintended Effects of Orphan Product Designation for Rare Neurological Diseases, especially Table 2: Blockbuster drugs that have obtained orphan drug designation [read post]
19 Sep 2019, 9:59 am
Andrew Pollack's article in National Review notes that the Broward County school district had adopted the Obama Administration's lenient discipline policy based on the "school to prison pipeline" narrative that allowed the deeply disturbed Cruz to remain on campus. [read post]
8 Sep 2011, 12:32 pm
Congress might provide a do-over for a drug firm that inadvertently missed filing for a patent extension by a day or two, and in so doing spare the prominent law firm WilmerHale a possible malpractice payout [Andrew Pollack, New York Times] Tags: lawyers, patent law, politics Related posts Reins of power dept. (0) Lawyers and White House nominations (0) Docs vs. lawyers (0) “Why lawyers rule the U.S…. [read post]
28 Oct 2009, 2:45 pm
"Reporter Andrew Pollack wrote that only 4 of the 14 disease team projects approved by CIRM today involve embryonic stem cells. [read post]
6 Mar 2009, 9:39 am
Analysts said the new price was likely to entice many more Genentech shareholders to tender their shares, The New York Times's Andrew Pollack reports. [read post]
24 Jun 2011, 9:52 am
Andrew Pollack wrote that Thomas was "taking over at a time when the state's fiscal crisis could jeopardize [read post]
4 May 2018, 6:00 am
The New York Times reported on Tuesday that Andrew Pollack filed the suit in Broward County court on behalf of his deceased daughter, The post Parkland Father Files Suit Against ‘Coward’ Sheriff’s Deputy appeared first on Legal Reader. [read post]
21 Feb 2009, 9:55 pm
Andrew Pollack in the NYT has a piece titled Crop Scientists Say Biotechnology Seed Companies Are Thwarting Research which includes the text:"No truly independent research can be legally conducted on many critical questions," the scientists wrote in a statement submitted to the Environmental Protection Agency. [read post]
2 Sep 2009, 9:59 pm
Written by Andrew Pollack, one of the paper's senior business and technology writers, the article highlights the interplay between scientific interest and business opportunity driving this phenomenon. [read post]
